Skip to content

Effect of oral minoxidil in treatment of androgenic alopecia

Comparison of the Effectiveness of topical and oral Minoxidil in the treatment of androgenic alopecia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220117053743N1
Enrollment
60
Registered
2022-03-11
Start date
2022-04-04
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia

Interventions

Intervention 1: Intervention group: A group of 30 patients will be administered with minoxidil capsules at a dose of one milligram per day for six months. Intervention 2: Control group: A group of 30

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with male pattern alopecia according to Hamilton and Norwood system are in grade 2-4 Patients with Female pattern alopecia according to the Ludwig system are in grade 1-2

Exclusion criteria

Exclusion criteria: Cardiovascular disease and hypotension Kidney Diseases History of drug allergy Pregnancy Lactation

Design outcomes

Primary

MeasureTime frame
Standardized global photography. Timepoint: Before the start of the study and 3, 6 months after the start of the intervention. Method of measurement: Based on scoring by two dermatologist.;Dermoscopy imaging. Timepoint: Before the start of the study and 3, 6 months after the start of the intervention. Method of measurement: Based on scoring by two dermatologist.

Secondary

MeasureTime frame
Change in hair density. Timepoint: At the beginning of the study (before the intervention) and 3, 6 months after the intervention. Method of measurement: Scoring by two dermatologists.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAida Farmani

Esfahan University of Medical Sciences

aida.farmani.med@gmail.com+98 31 3261 6408

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026